WealthTrust Asset Management’s ResMed RMD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$620K Sell
3,183
-137
-4% -$28.4K 0.34% 54
2026
Q1
$745K Sell
3,320
-27
-0.8% -$6.73K 0.45% 43
2025
Q4
$806K Sell
3,347
-75
-2% -$19.2K 0.56% 42
2025
Q3
$937K Sell
3,422
-166
-5% -$45.3K 0.65% 35
2025
Q2
$926K Buy
3,588
+20
+0.6% +$4.77K 0.69% 35
2025
Q1
$799K Buy
+3,568
New +$833K 0.59% 38

Other funds holding RMD

WealthTrust Asset Management's RMD Position: Q2 2026 in Review

WealthTrust Asset Management reduced its ResMed (RMD) stake by 4.1% in Q2 2026, selling an estimated $28.4K and leaving 3,183 shares worth $620K. The position accounts for 0.34% of the portfolio, ranked #54.

WealthTrust Asset Management first reported a position in RMD in Q1 2025 and has held it in 6 quarters since. The position peaked at $937K in Q3 2025. 882 funds tracked by Wall St. Rank hold RMD as of Q2 2026.

  • WealthTrust Asset Management held 3,183 shares of ResMed worth $620K as of Q2 2026.
  • WealthTrust Asset Management sold 137 ResMed shares in Q2 2026, an estimated $28.4K.
  • ResMed made up 0.34% of WealthTrust Asset Management's portfolio in Q2 2026, its #54 holding.
  • WealthTrust Asset Management first reported a position in ResMed in Q1 2025 and has held it in 6 quarters since.
  • WealthTrust Asset Management's ResMed position peaked at $937K in Q3 2025.
  • 882 funds tracked by Wall St. Rank held ResMed as of Q2 2026.

Based on WealthTrust Asset Management's 13F filing for Q2 2026, filed 27 Jul 2026.